Medical mycology journal最新文献

筛选
英文 中文
Kerion Celsi due to Microsporum canis in an Adult Woman, Treated Successfully with Fosravuconazole. 成年女性犬小孢子虫引起的角状细胞瘤用福司伐康唑治疗成功。
IF 1
Medical mycology journal Pub Date : 2023-01-01 DOI: 10.3314/mmj.22-00025
Harunari Shimoyama, Haruka Taira, Kazuo Satoh, Takashi Tamura, Ayaka Yo, Yoshihiro Sei, Koichi Makimura, Yoshihiro Kuwano
{"title":"Kerion Celsi due to Microsporum canis in an Adult Woman, Treated Successfully with Fosravuconazole.","authors":"Harunari Shimoyama,&nbsp;Haruka Taira,&nbsp;Kazuo Satoh,&nbsp;Takashi Tamura,&nbsp;Ayaka Yo,&nbsp;Yoshihiro Sei,&nbsp;Koichi Makimura,&nbsp;Yoshihiro Kuwano","doi":"10.3314/mmj.22-00025","DOIUrl":"https://doi.org/10.3314/mmj.22-00025","url":null,"abstract":"<p><p>A 64-year-old woman presented with a fist-sized, severely painful lesion with scales, crusts, pustules, erythema with subcutaneous abscess, and hair loss on the left temporal region. Direct microscopic examination revealed a large number of spores around the hair, which indicated ectothrix hair invasion, and some hyphae were also found. Histopathological examination showed significant inflammatory cell infiltration from the dermis to the subcutaneous tissues and into the hair follicles, destruction of the hair follicles with granulomatous reactions, and fungal masses along the hair within the hair follicles. Microsporum canis was identified based on morphological features via culture method and molecular biological analysis of the internal transcribed spacer region DNA sequence. The patient was diagnosed with kerion celsi caused by M. canis. For treatment of kerion celsi, we chose an oral antifungal agent, fosravuconazole (FRVCZ), which has been available since 2018 only in Japan. Clinical symptoms were cured in 12 weeks without scarring. No side effects were observed during oral administration of FRVCZ. The results of our case and several previous reports suggest that FRVCZ is effective in treating various types of dermatomycoses.</p>","PeriodicalId":18325,"journal":{"name":"Medical mycology journal","volume":"64 2","pages":"37-43"},"PeriodicalIF":1.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9615222","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Trichophyton tonsurans Infection]. [毛癣菌感染]。
IF 1
Medical mycology journal Pub Date : 2023-01-01 DOI: 10.3314/mmj.23-001
Taketoshi Futatsuya, Kazushi Anzawa, Takashi Mochizuki, Akira Shimizu
{"title":"[Trichophyton tonsurans Infection].","authors":"Taketoshi Futatsuya,&nbsp;Kazushi Anzawa,&nbsp;Takashi Mochizuki,&nbsp;Akira Shimizu","doi":"10.3314/mmj.23-001","DOIUrl":"https://doi.org/10.3314/mmj.23-001","url":null,"abstract":"<p><p>Trichophyton tonsurans infection has been prevalent among individuals involved in contact sports in Japan since about 2000. The present review focuses on its diagnosis, molecular epidemiology, drug susceptibility, and infection control. The most commonly observed lesions of T. tonsurans, an anthropogenic dermatophyte, are tinea corporis and tinea capitis. However, the presence of asymptomatic carriers must be considered for infection control. Genotypic epidemiology using restriction fragment length polymorphisms (RFLP) in the non-transcribed spacer (NTS) region of the ribosomal RNA gene showed a lack of diversity of genotypes, and only the NTS I genotype is detected at present. In regard to drug susceptibility, terbinafine drug resistance has not been found to be associated with the RFLP genotypes, and it is assumed that there are no terbinafine-resistant strains in Japan. T. tonsurans coexisted with other fungi and bacteria in the scalp of asymptomatic carriers without affecting species diversity. T. tonsurans is an anthropogenic dermatophyte and may be difficult for the human immune system to eliminate. During an infection outbreak, screening of infection and treatment including asymptomatic carriers are essential to eradicate the infection.</p>","PeriodicalId":18325,"journal":{"name":"Medical mycology journal","volume":"64 3","pages":"49-54"},"PeriodicalIF":1.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10127438","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
A Case of Nail Yellow Discoloration due to Topical Treatment of Onychomycosis with Luliconazole 5% Nail Solution. 5%吕立康唑甲液局部治疗甲真菌病甲变黄1例。
IF 1
Medical mycology journal Pub Date : 2023-01-01 DOI: 10.3314/mmj.22-00030
Tomotaka Sato, Norihito Fukada, Akihiko Kinjo, Ryuta Akimoto, Hisashi Kobayashi, Satoshi Fukuzumi
{"title":"A Case of Nail Yellow Discoloration due to Topical Treatment of Onychomycosis with Luliconazole 5% Nail Solution.","authors":"Tomotaka Sato,&nbsp;Norihito Fukada,&nbsp;Akihiko Kinjo,&nbsp;Ryuta Akimoto,&nbsp;Hisashi Kobayashi,&nbsp;Satoshi Fukuzumi","doi":"10.3314/mmj.22-00030","DOIUrl":"https://doi.org/10.3314/mmj.22-00030","url":null,"abstract":"<p><p>A woman in her 70s had onychomycosis that was treated with topical luliconazole solution. Her nails changed color to yellow due to the treatment and exposure to sunlight. Avoidance of sunlight and continuous application of luliconazole resolved the discoloration and were effective for the treatment of onychomycosis one year after the first visit.</p>","PeriodicalId":18325,"journal":{"name":"Medical mycology journal","volume":"64 2","pages":"45-47"},"PeriodicalIF":1.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9561187","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Invasive Malassezia Infections. 侵袭性马拉色菌感染。
IF 1
Medical mycology journal Pub Date : 2023-01-01 DOI: 10.3314/mmj.23-003
Masato Tashiro, Takahiro Takazono, Koichi Izumikawa
{"title":"Invasive Malassezia Infections.","authors":"Masato Tashiro, Takahiro Takazono, Koichi Izumikawa","doi":"10.3314/mmj.23-003","DOIUrl":"https://doi.org/10.3314/mmj.23-003","url":null,"abstract":"<p><p>The Malassezia species are dimorphic fungi that require lipids such as olive oil for their growth. They are constituents of the normal human skin microbiota and can affix to the host or other surfaces through the establishment of biofilms. Malassezia species are accountable for superficial mycoses like folliculitis. Additionally, they are capable of causing invasive infections, such as of the bloodstream, in neonates and immunocompromised patients, albeit infrequently. Catheter-associated bloodstream infections in neonates are the most commonly reported invasive cases. Remarkably, unlike other invasive fungal infections, neutropenia and the use of broad-spectrum antibiotics do not seem to contribute to the risk of invasive Malassezia infections. Nosocomial outbreaks of Malassezia infections have been reported. While most cases of invasive Malassezia infection are fungemia, they seldom give rise to disseminated lesions in various organs. The diagnosis can be confirmed by the visualization of characteristic yeasts through histologic or cytologic examination of a biopsy or needle aspiration specimen, or via positive culture results from sterile sites. The prognosis for invasive Malassezia infection is generally favorable, with few reports of treatment failure. Nevertheless, due to the limited number of cases, evidence-based treatment recommendations are wanting. Management of invasive Malassezia infections linked to central venous catheters includes removal of the catheter, cessation of intravenous lipid emulsion, and intravenous administration of appropriate antifungal agents.</p>","PeriodicalId":18325,"journal":{"name":"Medical mycology journal","volume":"64 4","pages":"79-83"},"PeriodicalIF":1.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138460788","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
A Case of Kerion Celsi due to Trichophyton tonsurans. 由毛癣菌引起的角膜炎1例。
IF 1
Medical mycology journal Pub Date : 2023-01-01 DOI: 10.3314/mmj.22-00032
Risa Ikutama, Yumi Ogawa, Takasuke Ogawa, Rui Kano, Masataro Hiruma, Shigaku Ikeda
{"title":"A Case of Kerion Celsi due to Trichophyton tonsurans.","authors":"Risa Ikutama,&nbsp;Yumi Ogawa,&nbsp;Takasuke Ogawa,&nbsp;Rui Kano,&nbsp;Masataro Hiruma,&nbsp;Shigaku Ikeda","doi":"10.3314/mmj.22-00032","DOIUrl":"https://doi.org/10.3314/mmj.22-00032","url":null,"abstract":"<p><p>The patient was a 13-year-old boy who was a member of the judo club at his junior high school. Approximately 1 week prior to his presentation, he developed multiple erythematous pilaris papules on his occipital area and was treated by a local doctor. The erythematous lesions expanded to 10 × 10 cm, showing granulation with drainage and strong spontaneous pain. At this point, he visited our hospital. He was diagnosed with kerion celsi due to Trichophyton tonsurans by fungal examination. The patient was treated with terbinafine (125 mg/day) for 6 weeks, and a brush test at 6 weeks was negative. All 18 members of the judo club, including this patient, were investigated; brush tests were positive in 4 cases, and one was positive for tinea corporis alone. The patient's family members parents were both negative. When an athlete is diagnosed with ringworm, T. tonsurans infection should be considered, and testing and treatment of family members and fellow athletes should be carried out to prevent the spread of infection.</p>","PeriodicalId":18325,"journal":{"name":"Medical mycology journal","volume":"64 3","pages":"73-77"},"PeriodicalIF":1.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10118266","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Antifungal Susceptibility Testing for Microsporum canis from Cats in Japan. 日本猫源犬小孢子菌的药敏试验。
IF 1
Medical mycology journal Pub Date : 2023-01-01 DOI: 10.3314/mmj.22-00014
Rui Kano, Mai Watanabe, Hitoshi Tsuchihashi, Takasuke Ogawa, Yumi Ogawa, Etsuko Komiyama, Yusuke Hirasawa, Masataro Hiruma, Shigaku Ikeda
{"title":"Antifungal Susceptibility Testing for Microsporum canis from Cats in Japan.","authors":"Rui Kano,&nbsp;Mai Watanabe,&nbsp;Hitoshi Tsuchihashi,&nbsp;Takasuke Ogawa,&nbsp;Yumi Ogawa,&nbsp;Etsuko Komiyama,&nbsp;Yusuke Hirasawa,&nbsp;Masataro Hiruma,&nbsp;Shigaku Ikeda","doi":"10.3314/mmj.22-00014","DOIUrl":"https://doi.org/10.3314/mmj.22-00014","url":null,"abstract":"<p><p>Control of infection caused by Microsporum canis in pet animals are important for prevention of zoonosis. Treatments for animal dermatophytosis have generally consisted of itraconazole (ITZ) and terbinafine (TRF); however, a TRF-resistant M. canis strain from a case of feline dermatophytosis has been reported. In the present study, we examined the in vitro susceptibility of clinical isolates of M. canis to new antifungal drugs, such as ravuconazole (RVZ) and luliconazole (LCZ). The results indicated that RVZ and LCZ are more effective than ITZ and TRF. Therefore, oral administration of RVZ or topical application of LCZ may serve as new treatment options.</p>","PeriodicalId":18325,"journal":{"name":"Medical mycology journal","volume":"64 1","pages":"19-22"},"PeriodicalIF":1.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10829219","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Mycobiome and Mycobiome-Associated Diseases. 真菌组和真菌组相关疾病。
IF 1
Medical mycology journal Pub Date : 2023-01-01 DOI: 10.3314/mmj.23-002
Mao Hagihara, Hideo Kato, Yuichi Shibata, Takumi Umemura, Tadashi Ariyoshi, Jun Hirai, Nobuhiro Asai, Nobuaki Mori, Hiroshige Mikamo
{"title":"Mycobiome and Mycobiome-Associated Diseases.","authors":"Mao Hagihara,&nbsp;Hideo Kato,&nbsp;Yuichi Shibata,&nbsp;Takumi Umemura,&nbsp;Tadashi Ariyoshi,&nbsp;Jun Hirai,&nbsp;Nobuhiro Asai,&nbsp;Nobuaki Mori,&nbsp;Hiroshige Mikamo","doi":"10.3314/mmj.23-002","DOIUrl":"https://doi.org/10.3314/mmj.23-002","url":null,"abstract":"<p><p>The human body is host to a large number of commensal microbial species such as bacteria, fungi, and viruses. Among these, the human mycobiome is often neglected as a potential cause of disease, as it is thought to be comparatively much less abundant and less diverse than the human bacteriome. Additionally, most fungi are not easily cultured, even in specific media. Hence, their study has been limited to date, mainly because of the unavailability of methods used for their detection. However, the utilization of a novel metagenomic methodology will enable the identification of well-characterized mycobiomes in several parts of the human body and broaden our knowledge of their contribution to human health and disease. In this article, we review the role of the human mycobiome in the gut, respiratory organs, skin, genital tract, and carcinogenesis, highlighting the correlations between the human mycobiome and mycobiome-associated diseases.</p>","PeriodicalId":18325,"journal":{"name":"Medical mycology journal","volume":"64 3","pages":"55-62"},"PeriodicalIF":1.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10118265","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
In vitro Azole Susceptibility Testing of Japanese Isolates of Terbinafine-Resistant Trichophyton indotineae and Trichophyton rubrum. 耐特比萘芬日本分离株吲哚毛癣菌和红毛癣菌体外唑类药敏试验。
IF 1
Medical mycology journal Pub Date : 2023-01-01 DOI: 10.3314/mmj.22-00021
Junichiro Hiruma, Utako Kimura, Hiromitsu Noguchi, Masataro Hiruma, Kazutoshi Harada, Rui Kano
{"title":"In vitro Azole Susceptibility Testing of Japanese Isolates of Terbinafine-Resistant Trichophyton indotineae and Trichophyton rubrum.","authors":"Junichiro Hiruma,&nbsp;Utako Kimura,&nbsp;Hiromitsu Noguchi,&nbsp;Masataro Hiruma,&nbsp;Kazutoshi Harada,&nbsp;Rui Kano","doi":"10.3314/mmj.22-00021","DOIUrl":"https://doi.org/10.3314/mmj.22-00021","url":null,"abstract":"<p><p>Multi-antifungal-resistant strains of Trichophyton indotineae and Trichophyton rubrum have been isolated in Japan. In the present study, we examined the in vitro susceptibility of terbinafine (TRBF) -resistant isolates of T. indotineae and T. rubrum to efinaconazole (EFCZ) and luliconazole (LUCZ). In all isolates, the minimum inhibitory concentrations were ≥ 32 mg/l for TRBF, < 0.03 to 16 mg/l for itraconazole, < 0.03 to 16 mg/l for ravuconazole, < 0.03 to 0.5 mg/l for LUCZ, and < 0.03 to 4 mg/l for EFCZ. Of note, T. rubrum NUBS21012 and T. indotineae NUBS 19006<sup>T</sup> showed resistance to LUCZ and/or EFCZ unlike the other isolates.</p>","PeriodicalId":18325,"journal":{"name":"Medical mycology journal","volume":"64 1","pages":"23-25"},"PeriodicalIF":1.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10829221","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Treatment responses in patients with chromoblastomycosis to itraconazole in Madagascar. 马达加斯加伊曲康唑对嗜铬菌病患者的治疗效果。
IF 1
Medical mycology journal Pub Date : 2022-10-26 DOI: 10.1093/mmy/myac086
F. Sendrasoa, V. Ratovonjanahary, T. Rasamoelina, L. Ramarozatovo, F. R. Rabenja
{"title":"Treatment responses in patients with chromoblastomycosis to itraconazole in Madagascar.","authors":"F. Sendrasoa, V. Ratovonjanahary, T. Rasamoelina, L. Ramarozatovo, F. R. Rabenja","doi":"10.1093/mmy/myac086","DOIUrl":"https://doi.org/10.1093/mmy/myac086","url":null,"abstract":"INTRODUCTION\u0000Chromoblastomycosis is a chronic fungal infection of the skin and subcutaneous tissue caused by several pigmented fungi. It is frequently found in tropical and subtropical areas like Madagascar. This study primarily discusses the effects of antifungal therapy while also describing the epidemiological, clinical, and pathological features of CBM in our patients.\u0000\u0000\u0000METHODS\u0000From March 2013 to January 2019, a descriptive prospective study on chromoblastomycosis patients was undertaken. The study included patients with CBM who had received antifungal treatment for at least 3 months. Itraconazole 200 mg was given to patients every day for more than 3 months. Results were assessed at the 6th and 12th months, and classified as improvement, cure, or failure.\u0000\u0000\u0000RESULTS\u000029 cases of chromoblastomycosis were included. The mean age of patients was 42.02 years. They primarily worked in rural areas. Infected men were more prevalent. At the end of the 12th month of itraconazole therapy, 3 patients presented major responses, 14 patients had minor responses to treatment, and 12 had been lost to follow up. The clinical response of CBM to treatment was correlated to the severity and the long course of CBM. When compared to CBM caused by Cladophialophora, CBM caused by Fonsecaea showed a greater clinical response.\u0000\u0000\u0000CONCLUSION\u0000These findings demonstrated that chromoblastomycosis lesions are recalcitrant and difficult to treat.","PeriodicalId":18325,"journal":{"name":"Medical mycology journal","volume":"29 24 1","pages":""},"PeriodicalIF":1.0,"publicationDate":"2022-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73097727","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
P305 Cirrhosis and fungal infections-a cocktail for catastrophe: a systematic review and meta-analysis with machine learning 肝硬化和真菌感染——灾难的鸡尾酒:系统回顾和机器学习的荟萃分析
IF 1
Medical mycology journal Pub Date : 2022-09-01 DOI: 10.1093/mmy/myac072.P305
N. Verma, Shreya Singh, Akash Roy, A. Valsan, P. Garg, Pranita Pradhan, Arunaloke Chakrabarti, Meenu Singh
{"title":"P305 Cirrhosis and fungal infections-a cocktail for catastrophe: a systematic review and meta-analysis with machine learning","authors":"N. Verma, Shreya Singh, Akash Roy, A. Valsan, P. Garg, Pranita Pradhan, Arunaloke Chakrabarti, Meenu Singh","doi":"10.1093/mmy/myac072.P305","DOIUrl":"https://doi.org/10.1093/mmy/myac072.P305","url":null,"abstract":"Abstract Poster session 2, September 22, 2022, 12:30 PM - 1:30 PM Objectives We evaluated the magnitude and factors contributing to poor outcomes among cirrhosis patients with fungal infections (FIs). Methods We searched PubMed, Embase, Ovid, and WOS and included articles reporting mortality in cirrhosis with FIs. We pooled the point and relative-risk (RR) estimates of mortality on random-effects meta-analysis and explored their heterogeneity (I2) on subgroups, meta-regression, and machine learning (ML). We assessed the study quality through New-Castle-Ottawa-Scale and estimate-asymmetry through Eggers regression (CRD42019142782). Results Of 4345, 34 studies (2134 patients) were included (good/fair/poor quality: 12/21/1). Pooled mortality of FIs was 64.1% (95%CI: 55.4-72.0, 12: 87%, P <.01), which was 2.1 times higher than controls (95%CI: 1.8-2.5, 12:89%, P <.01). Higher CTP (MD: +0.52, 95%CI: 0.27-0.77), MELD (MD: +2.75, 95% CI: 1.21-4.28), organ failures, and increased hospital stay (30 vs. 19 days) was reported among cases with FIs. Patients with ACLF (76.6%, RR: 2.3), and ICU-admission (70.4%, RR: 1.6) had the highest mortality. The risk was maximum for pulmonary-FIs (79.4%, RR: 1.8), followed by peritoneal-FIs (68.3%, RR: 1.7) and fungemia (55%, RR: 1.7). The mortality was higher in FIs than bacterial (RR: 1.7) or no-infections (RR: 2.9). Estimate-asymmetry was evident (P <.05). Up to 8 clusters and 5 outlier studies were identified on ML, and the estimate-heterogeneity was eliminated on excluding such studies. Conclusions A substantially worse prognosis, poorer than bacterial infections in cirrhosis patients with FIs indicates an unmet need for improving fungal diagnostics and therapeutics in this population. ACLF and ICU admission should be included in host criteria for defining IFIs.","PeriodicalId":18325,"journal":{"name":"Medical mycology journal","volume":"1 1","pages":""},"PeriodicalIF":1.0,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90248010","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信